Does ICATIBANT Cause Injection site erythema? 134 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 134 reports of Injection site erythema have been filed in association with ICATIBANT (Icatibant). This represents 2.5% of all adverse event reports for ICATIBANT.
134
Reports of Injection site erythema with ICATIBANT
2.5%
of all ICATIBANT reports
2
Deaths
37
Hospitalizations
How Dangerous Is Injection site erythema From ICATIBANT?
Of the 134 reports, 2 (1.5%) resulted in death, 37 (27.6%) required hospitalization, and 5 (3.7%) were considered life-threatening.
Is Injection site erythema Listed in the Official Label?
Yes, Injection site erythema is listed as a known adverse reaction in the official FDA drug label for ICATIBANT.
What Other Side Effects Does ICATIBANT Cause?
Hereditary angioedema (2,221)
Drug ineffective (506)
Product dose omission issue (421)
Weight decreased (386)
Weight increased (367)
Product use issue (332)
Injection site pain (331)
Inappropriate schedule of product administration (305)
Headache (294)
Malaise (262)
What Other Drugs Cause Injection site erythema?
ETANERCEPT (17,736)
DUPILUMAB (8,818)
ADALIMUMAB (8,563)
TIRZEPATIDE (3,844)
TERIPARATIDE (3,453)
GLATIRAMER (2,560)
IXEKIZUMAB (2,144)
ENBREL (1,879)
EVOLOCUMAB (1,754)
HUMIRA (1,654)
Which ICATIBANT Alternatives Have Lower Injection site erythema Risk?
ICATIBANT vs ICHTHAMMOL\ZINC
ICATIBANT vs ICLUSIG
ICATIBANT vs ICODEXTRIN
ICATIBANT vs ICOSAPENT
ICATIBANT vs ICOSAPENT ETHYL